Drug Profile
2-Methoxyestradiol - Amrad
Alternative Names: 2-ME - Amrad; 2-ME2 - AmradLatest Information Update: 05 Mar 2003
Price :
$50
*
At a glance
- Originator Zenyth Therapeutics
- Class Antineoplastics; Estradiol congeners; Estrenes; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Asthma
Most Recent Events
- 05 Mar 2003 No development reported - Preclinical for Asthma in Australia (unspecified route)
- 31 Dec 1998 Preclinical trials in Asthma in Australia (unspecified route)